Microsoft, Amgen, Honeywell International, Booking Holdings and Stryker have been included in this Analyst Blog.

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

11:41am, Wednesday, 15'th Jun 2022 Zacks Investment Research
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.

Top Research Reports for Microsoft, Amgen & Honeywell

05:13pm, Tuesday, 14'th Jun 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amgen Inc. (AMGN), and Honeywell International Inc. (HON).

TG Therapeutics (TGTX) Soars 18.7%: Is Further Upside Left in the Stock?

01:20pm, Thursday, 09'th Jun 2022 Zacks Investment Research
TG Therapeutics (TGTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

5 High-Quality Ray Dalio Stocks Near 52-Week Lows

05:42pm, Wednesday, 08'th Jun 2022
According to current portfolio statistics, a Premium feature of GuruFocus, five stocks in Bridgewater Associates' first-quarter 13F equity portfolio that have high business predictability and are trad

3 Disruptive Tech Stocks to Go All In on Now

08:41am, Monday, 06'th Jun 2022
Disruptive tech stocks boast unique competitive advantages as well as sticky consumer and global footprints. The post 3 Disruptive Tech Stocks to Go All In on Now appeared first on InvestorPlace.

6 Stocks To Buy That Are Near 52-Week Lows

05:14pm, Wednesday, 01'st Jun 2022 Benzinga
Weakness in the S&P 500 has made life unpleasant for investors so far in 2022, but it has also created buying opportunities in a handful of high-quality stocks. Long-term investors looking to buy the

Stryker's (SYK) Q Guidance System Receives FDA Approval

02:01pm, Wednesday, 01'st Jun 2022 Zacks Investment Research
Stryker's (SYK) Q Guidance System is expected to be a procedural ecosystem for surgeons during image-guided surgery following the receipt of the FDA approval.
Stryker (NYSE: SYK) has announced the launch of its EasyFuse Dynamic Compression System. These are the details.

Stryker: Innovation And Acquisition

04:33am, Monday, 23'rd May 2022
Stryker is a Dividend Champion with 28 consecutive years of dividend growth. Shares currently yield 1.20%. Stryker is a leader in the innovative med-tech sector that helps to advance healthcare solut

5 Reasons Why Today's Market Turmoil Shouldn't Shake You

11:30am, Saturday, 21'st May 2022 The Motley Fool
And it actually may be time to buy.
And it actually may be time to buy.

What 7 Analyst Ratings Have To Say About Stryker

05:03pm, Tuesday, 17'th May 2022 Benzinga
Analysts have provided the following ratings for Stryker (NYSE:SYK) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 2 0 0 Last 30D 1

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

12:01pm, Monday, 16'th May 2022 Zacks Investment Research
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE